Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary kidney cancer.

Jonathan J Hwang1, Edward M Uchio, W Marston Linehan

  • 1Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bldg#10, Room 2B47, Bethesda, MD 20892, USA.

The Urologic Clinics of North America
|December 19, 2003
PubMed
Summary

Advances in familial renal neoplasia genetics enable at-risk screening and understanding of sporadic kidney cancer. Ongoing research into cancer pathways will improve diagnostics and treatments for all renal cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum.

The Journal of urology·2026
Same author

Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.

The Journal of urology·2025
Same author

Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.

European urology·2025
Same author

A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant Therapy.

Advances in radiation oncology·2024
Same author

Impact of Clinical Factors on <sup>18</sup>F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study.

Advances in radiation oncology·2024
Same author

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Nature medicine·2024

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Familial renal neoplasia research has advanced significantly.
  • Key genes in hereditary renal cancer syndromes are being identified.
  • Understanding genetic abnormalities aids in studying sporadic kidney cancer.

Purpose of the Study:

  • To explore the genetic basis of familial renal neoplasia.
  • To investigate the role of identified genes in hereditary and sporadic kidney cancers.
  • To translate genetic discoveries into clinical applications.

Main Methods:

  • Genetic analysis of hereditary renal cancer syndromes.
  • Comparative studies of familial and sporadic renal neoplasia.
  • Delineation of carcinogenic pathways and oncogenic mechanisms.

Related Experiment Videos

Main Results:

  • Identification of key genes involved in renal cancer pathogenesis.
  • Opportunities for screening at-risk family members.
  • Insights into the genesis of sporadic renal cancers.

Conclusions:

  • Genetic discoveries are crucial for understanding kidney cancer development.
  • Continued research will integrate molecular knowledge into diagnostic and therapeutic strategies.
  • Future strategies will improve clinical management of all renal cancers.